|
---|
A message from Dr. Scott Betzelos, vice president of HMO Strategy and Affordability at BCN As I wrote in a previous column in this newsletter, Blue Care Network launched Blue Cross Personalized Medicine℠, a program that uses genetic testing to personalize medication treatments, in January 2023. I wanted to provide an update on the program — and an overview of our efforts over the past year — to provide a better understanding of why this program is so important. BCN has contracted with OneOme, an independent precision medicine company, to offer eligible BCN members pharmacogenomic (PGx) testing to aid health care providers with personalized medication guidance based on individual genetics and clinical guidelines. Participation in the program is at no additional cost to members. We anticipate the program will increase medication adherence and decrease the risk of adverse drug reactions. Eligible members are invited to participate based on advanced analytics, which determines who is most likely to benefit from PGx testing. PGx-certified pharmacists assess the testing results and offer recommendations to primary care physicians and prescribers. Test results remain private between the member and their providers and are never shared with BCN. We conducted a pilot program for eligible BCN Advantage℠ members last year. Following the pilot, eligible members, including BCN commercial members, started receiving invitations to participate in PGx testing beginning in January 2023. Pilot program results PGx testing resulted in 432 medication recommendations, which affected 396 members (90.8%). Early data from the pilot suggests a reduction in outpatient visits, emergency room visits and inpatient hospitalizations, as well as reduced total health care spending, among those who received PGx testing. What you can do
Ultimately, program success will depend on the active engagement of primary care providers who authorize testing, review test results and act upon clinical recommendations. Educational opportunities For the 2023 program, additional live virtual educational opportunities are planned for providers and their support staff, each focusing on a different therapeutic area:
Accessing training and other information If you haven’t yet registered for the provider training site, follow these steps:
You can find additional pharmacogenomics information on our provider portal by following these steps:
For more information |
*Blue Cross Blue Shield of Michigan and Blue Care Network don’t own or control this website. |